When machine learning algorithms are applied to data collected during the course of clinical care, it is generally accepted that the data has not been consistently collected. The absence of expected data elements is common and the mechanism through which a data element is missing often involves the clinical relevance of that data element in a specific patient. Therefore, the absence of data may have information value of its own. In the process of designing an application intended to support a medical problem list, we have studied whether the ''missingness'' of clinical data can provide useful information in building prediction models. In this study, we experimented with four methods of treating missing values in a clinical data set-two of them explicitly model the absence or ''missingness'' of data. Each of these data sets were used to build four different kinds of Bayesian classifiers-a naive Bayes structure, a human-composed network structure, and two networks based on structural learning algorithms. We compared the performance between groups with and without explicit models of missingness using the area under the ROC curve. The results showed that in most cases the classifiers trained using the explicit missing value treatments performed better. The result suggests that information may exist in ''missingness'' itself. Thus, when designing a decision support system, we suggest one consider explicitly representing the presence/absence of data in the underlying logic.
Introduction
Decision support technologies have become common in electronic healthcare systems. Most of the decision support tools in use today are based on rules originated by medical experts. In an effort to derive such systems from clinical data collected during routine care, we are exploring trainable decision support tools. A key challenge in formulating these tools is the variability of electronic clinical data. In particular, the frequent absence of data referenced in diagnostic logic can make development of diagnostic systems difficult [1, 2] . Here, we describe a novel approach that uses the information represented by the absence of data to help diagnose medical illness.
Purpose of our diagnostic models
For more than 40 years, there has been a strong interest in the development of diagnostic systems capable of using electronic clinical data to assist in the recognition of diseases and in tracking the status of those diseases. These tools have been used in experimental systems to educate, to collect data, and to explore the capabilities of computer-based tools in this realm. We have recently determined to explore a specific diagnostic modeling paradigm for the purpose of assessing the likelihood of a group of diseases. The goal is to recognize conditions that should be included in an electronic medical problem list, to compare these conditions to those already recorded in the problem list, and to propose those conditions, not yet recorded, for addition to this list. The result should be a problem list that is more complete, more timely, and more capable of supporting the process of clinical care.
Our focus in identifying problems for the problem list has been on computerized diagnostic systems that are derived from clinical data. The data used to train these systems are collected during the course of routine care. A key challenge in this effort has been the inconsistency of clinical data captured in the healthcare setting. This data is the foundation for any system that can, in real time, recognize clinical conditions and bring them to the attention of clinicians. Moreover, in a system built on trainable decision support tools, an ability to deal with inconsistently collected data is necessary to successfully train the diagnostic application. Here, we describe our approach to training a prediction model, based on Bayesian network technologies, in the face of routinely collected, clinical data.
The problem list application
The medical problem list is an essential component of the problem-oriented medical record (POMR) proposed by Weed [3] in the 1960s. In the POMR, the clinician maintains a list of the patient's medical problems. As care is documented, he/she can relate the accumulating medical data to each problem and can assess the patient's condition in terms of the problems recorded. Plans for treatments or further evaluation are described in the context of the relevant problem. The POMR is an approach that helps clinicians organize complex medical data, focuses attention on each medical problem, and promotes treatment of the patient according to a structured and documented analysis. Since Weed proposed this method in the 1968, it has been extensively studied. It is taught in most medical schools and there is general agreement on its usefulness [4] [5] [6] [7] [8] [9] [10] . Since the 1990s, as the usage of electronic health record (EHR) has grown, efforts have focused on the electronic delivery of the POMR, including implementation of the problem list in EHRs [11, 12] , retrieval of relevant data for the problem list [13, 14] , and automation of identifying medical problems [14, 15] .
Our approach is to develop an expert system that can identify medical problems based on the clinical data in the EHR. This expert system will propose a list of candidate medical problems. The clinician can then pick the suggested medical problems from the candidate list as one of several ways of maintaining the problem list. This candidate list serves two potential functions. One is to notify the clinician of a problem that he/she may have overlooked. The other is to remind the clinician of important problems that he/she may be aware of but may have neglected to record in the problem list. The overall goal of this expert system is to assist physicians to identify all medical problems and to facilitate the completeness and timeliness of the medical problem list.
For the development of the expert system, we have chosen Bayesian networks (BNs) [16] [17] [18] as the problem prediction model and have applied machine learning algorithms to the EHR data to acquire the parameters for BNs. However, the incompleteness of clinical data, i.e., the frequent absence of data elements used in the models, makes this approach challenging. Some training algorithms require complete data sets to execute. The conversion from an incomplete data set to a complete one then becomes an issue. Other algorithms allow missing values but usually assume that the mechanism leading to missing values is random, which may not be true for clinical data. If the assumptions chosen are wrong, the learned BN model will be inaccurate. However, if the absence of a specific data element is derived from phenomena relevant to the medical problem, the observation of its absence may, in itself, be a legitimate information source for the problem list algorithm, both during training and at runtime, when an individual's problems are assessed.
It should be noted that, although the purpose of this system is to detect medical problems by using clinical information, the system for proposing problem is not intended to serve the same function as a computerized tool for diagnosis. Its goal is to facilitate the completeness of problem list rather than to exhibit diagnostic behavior similar to a physician's. Thus, every piece of information that serves this purpose, including the clinicians' recorded or implied decisions and actions, can and should be used to optimize the performance of the system. The system is designed not only to interpret the raw clinical data, but also to ''look over the physician's shoulder'' and infer from his actions the problems that have motivated them. These are problems that should be recorded in the medical problem list; this system should remind clinicians of their existence.
The challenge then is to utilize all possible information to infer the existence of clinical problems. The presence or absence of clinical data is a significant component of this information.
The failure to capture clinical data
An EHR is designed to capture clinical data and save it in electronic data storage. The presence of electronic data sources allows decision support technologies to be applied to enhance healthcare. However, a key challenge for advanced decision support technologies is the inconsistent character of the clinical data entered into EHRs. The timing, sequence, and other characters of the collected data can vary greatly from patient to patient. In particular, key data elements for the execution of a decision support system (DSS) may be missing from a patient's record. For example, a decision rule may require a serum lipase to be present, but no serum lipase has been ordered for the patient. The ''missingness'' of certain data elements often hinders the operation of a DSS.
On the other hand, the absence of data elements can be used to augment a DSS. Among various reasons why a data element is missing, some are associated with the clinician's response to the patient's condition. For example, when a physician sees the possibility of pneumonia in a patient, he/she usually orders chest X-ray. From the absence of chest X-ray orders in a patient's record, it can be inferred that the physician probably does not consider pneumonia to be among the patient's conditions. Thus, a DSS might profitably implement a rule stating that the absence of chest X-ray order (and the associated radiological data) decreases the possibility of pneumonia.
Statistical inference with missing data
Missing data is a common problem in data mining and statistical inference. According to Little and Rubin [19, 20] , mechanisms that lead to missing data can be categorized into three types: missing completely at random (MCAR), missing at random (MAR), and not missing at random (NMAR). Here, we use a simplified data set (Table 1) to explain these three mechanisms. The data set consists of patients' data of four variables: body temperature, white blood cell count (WBC), sputum culture result, and chest X-ray result. Each record in the data set contains four values corresponding to these four variables in a patient. This data set can be used to build a prediction model that can detect pneumonia. Some patients' chest X-ray results are not present.
• MCAR: the absence of a data element is not associated with any other value in the data set, observed or missing.
In the example data set, if the chest X-ray results are missing by a random sampling process, then the missing mechanism is MCAR. In this case, observing the missingness will not provide information in addition to observed values.
• MAR: this is a less restrictive assumption than MCAR; it indicates that the absence of a data element depends only on the observed values in the data set, not on missing ones. For the sample data set, if the X-ray results are missing only for patients whose body temperature is normal, WBC count is normal, and sputum culture is negative, then the missing mechanism is MAR. The implied information of missingness can be inferred from observed values.
• NMAR: the condition is the negation of MAR. The absence of a data element reflects its probable (missing) data value. If the missingness is due to some conditions related to the chest X-ray result, then the mechanism is NMAR. A physician may assess the lung's condition by subjective complaints and auscultation. These variables are not present in the sample data. A chest X-ray may not be considered necessary if the physician feels the patient's lungs are normal and, in most cases, this inference will be correct. The absence of chest X-ray does not depend on the observed data in the data set, but on the missing chest X-ray value guessed by the physician using some mechanism not reflected in the data. Under this circumstance, the missingness does contain information that cannot be inferred from observed values.
Several approaches to missing data have been used in developing trained diagnostic systems. If one does not consider the observation that the data is missing as a piece of supporting information, the methods for coping with missing values can be grouped into three main categories [20] : inference restricted to complete data, imputation-based approaches, and likelihood-based approaches.
The simplest approach to missing values is to discard the cases with missing values and do the analysis based only on the complete cases. However, this results in a biased sample of complete cases because the absence of data is not a random process.
In imputation-based methods, the missing values are filled in and the resultant data can be analyzed as a complete data set. Commonly imputed values are based on the value of known cases: the mean of the variable in either the whole data set or in select data subsets, or an estimated value from regression procedures on known variables. Multiple imputation methods, i.e., filling with more than one value, have been developed to avoid biasing the variances of imputed variables [21] .
There exist approaches that, rather than imputing data where values are missing, derive a prediction model by inferring the model's parameters from the existing data. Likelihood-based approaches are an example of these. They implement a model by attempting to find the set of model parameters that make the observed data most likely. The resulting system can then base future inferences on the parameters estimated in the context of that model. The expectation-maximization (EM) [22] algorithm is commonly used for finding maximum likelihood estimates in the face of incomplete data.
All the above methods are based on the assumption that the mechanism of missing data is ignorable (i.e., MCAR or MAR) and does not provide additional information. However, researchers have noticed that some mechanisms leading to missing data actually possess information, i.e., they represent NMAR, which are also called 'non-ignorable' missingness or 'informative' missingness [20, 23, 24] . Since the missingness mechanism contains information independent of the observed values, it requires an approach that can explicitly model the absence of data elements. Two approaches [25] are commonly used to representing missingness in data-missingness indicator and stratification. The former approach creates another dichotomous variable representing whether a variable has been observed; the latter fills the target variable with a nominal value, ''missing'', if the variable has not been observed.
A clinical data element can be absent because of any of the three mechanisms described above. The experiments described here reflect our belief that some mechanisms that lead to missing data in the clinical setting are NMAR. That is, the absence of data cannot be inferred or explained by other, existing data elements and therefore the information in ''missingness'' can be used to improve the performance of the expert system.
Bayesian networks as a modeling tool
For the problem list system described above, we have chosen to use Bayesian networks (BNs) [16] [17] [18] as the underlying model for the expert system. The ability of BNs to model uncertainty and causal relationships among variables makes them an attractive tool in a number of medical applications. BNs are based on a graphical formalism; in a BN, each variable is modeled as a node and the causal relationship between two variables may be represented as a directed arc. For each node, a conditional probability table or formula is supplied that represents the probabilities of each value of this node, given the conditions of its parents (i.e., all the nodes that have arcs pointed to this node). Fig. 1 shows an example of a BN.
BNs will provide the modeling and prediction system needed for our problem list application. The advantages of using BNs to model clinical expert systems include the following: (1) they can be used to predict a target variable in the face of uncertainty. (2) A causal relationship can be represented by an arc between two nodes and the conditional probabilities of one node conditioned on its parents. This provides a model that is intuitive to physicians and that can be used to generate explanations. (3) Properly designed BNs can provide a valid output when any subset of the modeled variables is present. In effect, the expected values of all missing variables are inferred from the variables that are presented.
There are many ways of acquiring the structure and parameters of a BN (i.e., the nodes and arcs, and the conditional probabilities). Based on the approach to defining a BN's structure and parameters, the methods can be categorized into the following [26] :
• Naive or simple Bayesian: all the independent variables are child nodes of the dependent variable. The parameters can be learned from data or estimated by experts.
• All human-composed: human experts provide the nodes, the arcs, and the conditional probabilities. As the complexity of the network increases, it can become very demanding of expert time.
• Human-composed structure and machine-learned parameters learned from data: human experts provide the causal relationships, the network structure is designed using this information, and the parameters can be learned from data.
• All machine-learned: using one of the available Bayesian network structure learning algorithms, the network structure can be learned from data as well as the parameters.
Because the purpose of this study is to investigate the effect of using different models to explicitly represent missingness, we determined to test three of these four approaches in conjunction with different ways to express the absence of data. We used all but the approach in which humans compose the entire model; in this case, information derived from data has no effect on the network.
In summary, in this article we describe an approach to computing with missing data. The context is the problem list application described above. We have designed an experiment in which we prepared clinical data sets using different methods to deal with missing data elements. Two of these methods explicitly represent the absence of relevant data elements using stratification and missingness indicator approach, respectively. We then applied automated Bayesian network learning to these data sets to develop a system for predicting medical problems; the chosen problems are destined to be used in our computerized medical problem list. Finally, we compared the performance of different combinations of predictive models and data preparation methods.
While a number of BN-development approaches are used, the focus of this experiment was to determine whether missingness in medical domain contains information value or not. The improvement in performance was used as a measure of the information value provided by missingness. The result is an assessment of the merits of including ''missing'' data in algorithms for the detection of medical problems. It reflects a testing process using four training approaches and five diseases.
Materials and methods
The study was conducted using data extracted from the enterprise data warehouse (EDW) of Intermountain HealthCare (IHC) in Salt Lake City. The data was captured during routine clinical care documented in the HELP [27] hospital information system.
Five target diseases-acute pancreatitis, acute renal failure, asthma, urinary tract infection, and pneumonia-were selected for this study; they were chosen, from common diseases in the acute care setting, to represent different degrees of difficulty in terms of diagnosis. The modeling process began with the identification of variables for use in the prediction algorithms. For each disease, the authors referred to textbooks in internal medicine [28, 29] supplemented with authors' experiences gained from medical practice and training, and composed a list of related clinical variables. The data source (the EDW of IHC) was then explored to find data elements corresponding to listed clinical variables. In accordance with the selected diseases and their related variables, targeted data was retrieved from the source, transformed into the proper format, and processed as necessary to produce the different, experimental, missing value representations. The data was stored as separate data sets; the data sets were then used to train BN prediction models and to evaluate the models' performance (Fig. 2) .
As a part of this experiment, we chose to treat the data in four ways regarding missing values. These were A. To simply train the BN with no preprocessing to manage or infer missing values. B. To impute the missing value with the overall mean or mode of all available values in the data set. C. To augment each variable with an indicator state within the variable labeled ''missing'' for use whenever data was absent for a variable in a patient's data set (missingness stratification approach). D. To create an additional variable to represent missingness for each existing variable that was found to be absent in one or more patients (missingness indicator approach).
These procedures are detailed below. Using these four derived data sets, we tested the four Bayesian network classification methods for their ability to predict the presence of five medical diagnoses. We compared the performance of predictive systems trained with these data sets using the area under the receiver operating characteristic (ROC) curve.
The experiment described was focused specifically on comparing the performance of data sets with explicit representation of missing values (i.e., Treatments C and D) with those without (i.e., Treatments A and B). The intention was to determine whether the inclusion of missingness using either Treatments C or Treatment D would improve the predictive model's performance.
Data retrieval and preparation
Using the primary discharge diagnosis coded in ICD9, we identified ''positive'' patients who were discharged with any of the five target diseases as the primary diagnosis from the year 2000 to 2004. This provided a positive population for each disease. In addition, we adopted two approaches to selecting the ''negative'' patient groups (i.e., patients without the targeted disease as their primary diagnoses) for each disease. One approach was to randomly select from patients who were admitted through the emergency room and stayed in the hospital longer than 48 h; the other was to use patients from the other four disease groups as the negative patient group for the chosen disease. We then combined positive and negative patients into a patient set for each of the five diseases.
For each disease, we then retrieved a data set from the EDW, restricting it to that was collected during the first 48 h of the patient's hospitalization. The values for the retrieved data were stored in an extended name-value pair (unpivoted) format (Fig. 3a) and featured data redundancy as well as absent values. Through aggregation, attribute selection, and data pivoting, we transformed this data into the column-based (pivoted) format (Fig. 3b) that is required for general machine learning algorithms. Subsequently, we had 10 (five diseases combined with two negative patient approaches) data sets in the column-base format; each set corresponded to a targeted disease and contains data from positive and negative patients.
Missing value treatments
The processed data set for each disease was used to create four experimental data sets with different missing value treatments.
• Treatment A had no treatment for missing data. That is, the value of missing data would be left empty. The data set with its empty cells would be sent to the training algorithms, which would manage missing data according to their internal models.
• Treatment B had missing values imputed using the overall mean or mode from all available data for that variable within the same data set. Means were used for continuous variables, e.g., body temperature, WBC, and modes for categorical variables, e.g., wheezing (Yes/No). The data set was consequently made a complete one. Because Treatment C required discretization of any continuous data, all of the data sets went through identical equal-frequency binning discretization. Fig. 4 shows a simplified example of the missing value treatment process.
Bayesian learning methods
Four different Bayesian learning methods were applied to each of the four treated data sets produced for each disease. Every model was trained to predict the presence or absence of the disease represented as a BN node with dichotomous value. Training and testing data sets were derived (detailed in Section 2.5) from the treated data set. In the training phase, all information of the training set, including the disease's presence/absence, was provided to train the BN. In the testing phase, each patient's data, except the disease's presence/absence, was entered into the trained BN to infer the probability of the disease. The predicted disease probability and the known disease's presence/absence were then analyzed using the area under ROC curve.
The first algorithm (Model 1) of the four methods, was the naive Bayesian calculation [17] . It assumes conditional independence of all input variables given the output. It is a simple, efficient method to build classifiers. The training and testing were carried out using a Java program, built in-house, with the standard naive Bayesian calculation.
The second method (Model 2) uses the WinMine [18, 30] classifier, a tool that attempts to learn the optimal structure and conditional probability tables of the Bayesian network from data. The goal was to achieve a network structure more consistent with the underlying joint probability distribution of the data. Typically, the structure of naive Bayesian models is a significant simplification of the optimal structure.
Because, by default, the WinMine toolkit introduces a state of ''missing'' for each variable noted to have a missing value, the information associated with missing data is already modeled during the process of learning structure. Therefore, with WinMine, Treatment A (i.e., the data set including missing values but without any explicit missing representation) cannot be achieved. To avoid this effect when using WinMine, we introduced a third method (Model 3). We developed an application that uses the WinMine toolkit to learn network structure and then employed a second toolkit, Netica [31] , to learn the conditional probability tables.
Finally, a Bayesian network structure was composed by the first author (an example is shown in Fig. 5 ) using medical domain knowledge. The paradigm used to design these networks emphasized a ''causal'' model of disease; arrows were placed from the disease to each node representing a variable whose abnormalities are typically caused by that disease. The conditional probability tables were learned from the data sets using Netica (Model 4).
All these learning models used the standard or default settings for the applications used. Appendix A describes some details of the program settings for Models 2-4.
Evaluation of the Bayesian network-area under ROC curve
A standard approach to estimating the accuracy of a probabilistic, pattern-recognition system is the Area under the receiver operating characteristic curve (AUC) [32] . We used this metric to evaluate the accuracy of each approach to missing data (four approaches) for each diagnostic model (four models) in each disease (five diseases). Details of our approach are described below.
Training and testing with the bootstrapping process
Cross-validation was used to evaluate the performance of each system following the training process described above. The bootstrapping approach was chosen because it is (1) free of underlying distribution assumptions, (2) equal or better in accuracy than classical methods, and (3) simple and intuitive in implementation without using complex statistical formulae [33] . For each derived data set, we applied a 500 iteration bootstrapping cross-validation process (Appendix B) that repeatedly derived data sets for training and testing. During iteration, cases were sampled, with replacement, from the data set; the number of sampled cases was the same as the original data set. This sampled case collection is called the resampled data set. Because cases in the resampled set were sampled with replacement, some cases in the original data set were not selected; this collection is called the residual data set.
During each iteration, a Bayesian network was trained using the resampled data set, and tested using both the residual and resampled data sets. A weighted average of AUCs (detailed in Appendix B) was calculated for each iteration. The AUCs from these iterations were used to compare the accuracy of the systems produced from the different models/data sets.
Statistical analysis
The study was designed to compare the effect of approaches to representing the missing data. In other words, the comparison of AUCs among four data treatments is the focus of the experiment. The more specific question that motivated this experiment is whether an explicit representation of missingness improves the performance of prediction models or not. Thus, the null hypothesis is that the prediction performance of systems trained with data sets that explicitly represent the absence of data (Treatments C and D) is the same as that of systems trained with data sets which do not (Treatments A and B); the alternative hypothesis is that the prediction performance of systems trained with data sets treated by Treatments C and D is better than those based on Treatments A and B.
To test the hypothesis, we applied permutation tests (sometimes called randomization tests) [34] to rank sums of Treatments C and D. Some characteristics of this experiment restricted us from traditional approaches for statistical analysis: (1) the comparison was upon AUC, which is not normally distributed so classical ANOVA cannot be applied, (2) the focused comparison was two groups vs. the other two (Treatments A and B vs. C and D), and (3) one of the learning models (Model 2) did not allow Treatment A, which resulted in a special case with only three measurements instead of four. A permutation test has the flexibility to deal with all these limitations as long as an appropriate statistic is used. We chose to use the rank sum of Treatments C and D as the statistic to test. The distribution (or histogram) of all possible rank sums was created through a randomization process (Appendix B). The statistical significance (p value) of the observed rank sum was calculated using this distribution (i.e., one-tailed cumulative area of the distribution).
Four (or three in the case of Model 2, WinMine) performance estimates of each model/data set combination were ranked. Ranks of Treatments C and D were summed throughout each disease and throughout each model. Five disease rank sums, four model rank sums and one overall rank sum were calculated. Because we applied two strategies to prepare negative patients in the data sets, there were two sets of 10 rank sums-one set for each strategy. Significance levels (p value) of the rank sums were assessed by permutation tests.
Results
We retrieved data of over 5800 patients (Table 2) who were either discharged with a primary diagnosis that is one of the five diseases or in the randomly selected negative patient group. The variables selected as input for each of the diseases were chosen based on clinical relevance and data availability (Table 3 summarizes the data used and the availability of this data in our extracted data sets).
The resulting AUCs are shown in Tables 4 and 5. Table  4 's results reflect training and testing with the randomly selected negative group; Table 5 's results reflect training and testing using the other diseases as the negative group. In the tables, Treatments C and D, the ''missing'' state and the ''missing'' node, were generally ranked higher. The result of analysis, using rank sums and permutation tests, shows that ranks in treatment group (C and D) are significantly (p < 0.05) better than in group (A and B) in 8 out of 10 tests among diseases and 9 out of 10 tests among learning models; one test result among the learning models is borderline (p = 0.0594). One data set for asthma and one Fig. 5 . A part of the human-composed Bayesian network. It is simply naive Bayes. Some clinical variables are specific to the disease, e.g., BUN; others are common e.g., heart rate (HR). data set for pneumonia failed to show an improvement in performance.
Discussion

Possibly informative missingness
In the analysis, we compared the performance of prediction models using data sets with and without explicit representations of the absence of data elements. Our goal was to determine whether missingness contains information that can support the prediction of these diseases. In most of the cases, the data sets with explicit representations of data absence performed better than those without. The result confirms that at least part of the mechanism resulting in missing data is NMAR. If the mechanism is MCAR, the absence of data does not contain useful information; if MAR, the information associated with absence is redundant and could be inferred from observed values. In either case, the explicit modeling of missing values would not improve the performance. Thus, it would appear that the improvement is due to NMAR, i.e., missingness in this context does contain information value.
In the comparison, we treated all of the missing information in each test in the same way, i.e., all variables with instances of missing values had those values treated in the same way. The result revealed that the presence of explicit representations for missing data could improve performance.
A potential issue with the approach used is the possibility that only a subset of the variables provided with explicit representations for absent values contribute information. A pilot study of gradually adding missingness representation (Fig. 6) suggests that not all the missing indicators contribute to an improvement of the performance. In this study, the indicators were added in the descending order of the association (determined by v 2 statistics) of the data element's presence and the disease. The result implies that not all reasons for the absence of data are relevant for predicting the target disease. How to extract the maximum information from missingness is a part of our future work.
Limitations of training/testing data preparation
In the experiment, we used ICD9 primary diagnoses as the positive patient selection criteria and used clinical data collected during the first 48 h after admission. An ICD9 primary diagnosis only captures the main reason why the patient was admitted to the hospital. The patient may have additional medical problems, e.g., a pneumonia patient may have asthma as an underlying condition. Clinical data from patients with more than one targeted medical problems may be regarded as confounding sources for the classifiers' learning. To identify these multi-diseased patients, we have considered two options: one is physician chart review; the other is the use of secondary diagnoses. The former would take a considerate manual effort, which is not practical as the number of patients is large. The latter could possibly add more confounding because from the codes for secondary diagnoses one cannot tell when these illnesses affected the patient. It could be at a time prior to admission, or early or late in the patient's hospitalization.
On the other hand, some characteristics of the experiment could be expected to reduce the influence of possible confounding phenomena. First, the BNs were trained in the predicted model for each problem separately. That is, there was a BN node with a dichotomous value ('Yes' or 'No') for each problem. Second, the experiment was restricted to the clinical data collected within the first 48 h of hospitalization. This is the time when the primary discharge diagnosis (the disease responsible for bringing the patient to the hospital) might be expected to display its manifestations most strongly. Finally, if we had excluded patients with more than one targeted problem from the data sets, the training with a ''purified'' patient pool would not have represented the target patient population for the POMR, the ultimate goal of this research; in the real world, patients may have more than one medical problem. The optimization of patient selection for training the BNs (or other relevant predictive models) will require more investigations. In the experiment, we chose the ICD9 primary diagnoses for positive patient selection and tested two approaches for negative patient selection. The availability is the percentage of data available (not missing) in the data set. Variable type 'C' is continuous variable and 'D' is dichotomous.
The result also reveals some differences between the two approaches used to generating a negative patient group. With random selection of the negative patients, the performance is generally better than with the ''case vs. the others'' for asthma and pneumonia. This is probably because of the overlap in features between these two pulmonary problems. It is more challenging to detect each problem correctly when patients of the other pulmonary disease serve as a large part of the negative patient group.
When preparing the data for training without an explicit representation of missingness, we tested two data treatments-one was the ''as is'' data treatment (Treatment A) and the other was filling in with the overall mean or mode (Treatment B). Another common approach is to fill in with a specific value or a probability distribution that seems most appropriate; these values can be determined by human experts or automatic algorithms. We did not use the human-expert approach because it requires intensive manual work. As for the automatic approach to determining the fill-in value, all the Bayesian classifiers we used were capable of estimate an optimal value for missing data. If any of the data sets had been prepared by filling in missing values with values estimated from a model, the learned model and consequent performance would be expected to be identical to Treatment A.
Structure learning in Bayesian network training
Although, there are a few algorithms available for learning the Bayesian network structure, most algorithms require a complete data set, i.e., no missing data allowed. The WinMine Toolkit, which we used as the structurelearning tool, allows missing data, but it creates a ''missing'' state for each variable with missing values; this allows it to make an incomplete data set into a complete one. A potentially useful alternative, the structural EM algorithm [35] , can learn the structure and parameters from an incomplete data set but takes a much longer time to run.
Increased automation is an advantage of using a structure-learning tool for Bayesian network. Provided with the prepared data set, the application can generate a Bayesian network with its structure and parameters optimized for the data set. However, the learned structure may not look reasonable to a domain expert. The algorithm may create a structure that is statistically equivalent to a causal model but differs in nodal connections or it may optimize the structure for some features in the data that represent chance outcomes or bias. Determination of an optimal approach to acquiring a network structure that is also consistent with the causal structures that appeal to physicians will require further investigation. 
ROC analysis and practical considerations
In this study, we used the area under ROC curve as our performance measurement. The ROC curve is the 2-D plot of sensitivity and 1-specificity acquired by applying a sequence of arbitrary cut-off threshold to the probabilities generated by the predictive model. Unlike the error rate, the area under ROC curve is insensitive to the prevalence of disease in the data set. As long as the numbers of positive and negative cases in the data set are large enough so that both groups can represent the characteristics of the population, the area under ROC curve should be consistent independent of the proportions of positive and negative cases. However, when one chooses to implement a prediction model in a clinical environment, he/she will need to inspect ROC curves in detail and will need to select parameters for the system, including the prior probability of the disease and the cut-off threshold to achieve a targeted sensitivity and specificity.
For the problem list application we are developing, 90% sensitivity and 50% positive predictive value are considered the minimal requirements for the clinical environment. To choose a cut-off threshold, we will need to convert the positive predictive value to a specificity using other parameters such as the prior probability of the disease. For the predictive Bayesian network, the prior probabilities of disease may need to be recalibrated using the prior probability of the disease in the target population, because, as is common, our Bayesian networks are trained with data sets enriched with patients with the target disease. The probabilities will need to be adjusted to match those in the real environment.
Informative missingness in the problem list application
The diagnostic value derived from missing data appears to be useful for increasing the accuracy of the problem list application that we are developing. This application is designed to support the physician as he/she maintains an accurate and up-to-date problem list. The application will provide both a diagnostic and a reminding/prompting The AUCs are the results of 500 iterations of bootstrapping for training/testing of each data set. The experiment and analysis are identical to that of Table  4 , except the data sets are composed of each disease group of patients and the other disease groups as the negative group. function. The diagnostic function is provided by processing the information derived from the clinical parameters, present in the record. It attempts to recognize clinical conditions that can be presented to the physician as a ''second opinion'' interpreting this data and prompting problem documentation. The analysis presented here suggests that attention to missing data may improve the accuracy of the suggestions produced by this application.
On the other hand, the physician may not need diagnostic aid. She/he may be clear concerning the patient's condition, but may neglect to record this medical problem. Under these circumstances, the information derived from the clinical data present and from the physicians' behavior in not collecting select data elements will support the problem list application as it reminds the physician of the apparent problem and prompts appropriate documentation of this problem in the problem list.
Conclusions
In this article, we addressed data missingness issue when building clinical DSS, and reviewed different mechanisms through which data may be missing. Although absence of data is usually considered a hindrance to accurate computer-based diagnosis, we believed that sometimes the absence of data contains information value and thus can help in DSS development. In the context of the problem list application, some absence of data elements is the consequence of physician decisions and reflects aspects of the patient's condition.
Using data sets extracted from the EHR, we have tested the performance of BN prediction models that can detect and proposed medical problems. The result showed that BNs developed with data sets with missingness representations outperformed those without representations of missingness. Our conclusion is that the absence of some data elements in the data sets is informative: missingness representations can be used to create better prediction models.
This experiment treated missingness globally, i.e., for all variables in each model; it is likely that the absence of some variables is more informative than others. Further work comparing the relative contributions of the absence of different variables' will help pinpoint the mechanism through which missing data contributes to the recognition of medical problems.
This experiment was conducted as a part of the process of developing a system for proposing additions to an electronic problem list. However, missingness information may be useful in other circumstances where clinical processes routinely leave some data uncollected. The work described here may suggest approaches to representing missingness configurations in other contexts. We believe this type of information should not be overlooked. When building the underlying logic for a decision support system, we suggest that explicit missingness representations be routinely taken into consideration.
computers. It can be used to estimate various statistics from the original sample. This study used .632+ bootstrapping [36, 37] to estimate the AUC for a specific learning model/data set combination: B.1. The .632 bootstrapping Each bootstrap sample, which is of the same size of the original one, is resampled from the original sample. The process is resampling with replacement so one subject in the original sample can be resampled more than once. On average, 63.2% of subjects are included at least once in a bootstrap sample.
The model is then built from the bootstrap sample and tested on the residual data (about 36.8% subjects); the performance on the residual data is simply called test performance. The model is also tested on the bootstrap sample and the performance is called apparent performance or resubstitution performance.
In the .632 bootstrapping, the estimated performance is a weighted combination of the apparent and test performance:
Estimated performance = 0.368 · apparent performance + 0.632 · test performance.
B.2. The .632+ bootstrapping
The .632+ method, an extension of the .632 method, is designed to provide a better estimate when overfitting exists. The weights of combination for estimated performance are determined by the degree of overfitting R. R = (test performance À apparent performance)/(no information performance À apparent performance). w = 0.632/(1 À 0.368 · R). Estimated performance = (1 À w) · apparent performance + w · test performance.
Here, no information performance for the area under ROC curve is 0.5. When R is large (i.e., the trained model is overfitted on the training set), the weight for apparent performance approaches zero; the estimate depends more on the test performance. When R is small, the estimate is close to .632 bootstrapping. When R is zero, the estimate is equal to the estimate of .632 bootstrapping.
Appendix C. Permutation tests [34] If the null hypothesis was true in this study, data sets with Treatments C and D would render the same performance as Treatments A and B. That means that every ranking permutation has the same probability. For example, under the null hypothesis, ranking pair (1, 2, 3, 4) for Treatments A, B, C, D is equally possible to happen as (3, 4, 1, 2); however, if the alternate hypothesis is true, the latter is more possible.
Here, the rank sum of Treatments C and D were used as the test statistic. Each permutation of the ranking could produce a value for this statistic. For each possible value of this statistic, one could count the frequency of permutation. The significance level of a value of the test statistic can be calculated by the accumulated frequency:
Significance level of a value (m) = (sum of frequencies of values that are equal or less than m)/(the number of all permutations).
Use the ranking of four as an example:
The test statistic is the sum of ranks of last two elements. 
